GlassScriptPhysician profile
Jennifer T Hoffman
NPI 1306812854
$2,386.43
in general payments reported to CMS, 2019-2025
14 companies · $1,670 in 2025
The $1,670 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.55 · 2021: $29.89 · 2022: $15.27 · 2023: $164 · 2024: $475 · 2025: $1,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,418 · Food and Beverage: $865 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,417.86 |
| Food and Beverage | $864.86 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,417.86 | 2025 | |
| Abbvie INC. | $251.23 | 2020-2025 | |
| Braeburn INC. | $161.09 | 2024-2025 | Brixadi |
| Indivior INC. | $148.70 | 2023-2025 | Sublocade |
| Alkermes, INC. | $144.60 | 2023-2025 | Vivitrol, Vivitrol |
| Uswm, LLC | $63.24 | 2023 | Lucemyra |
| Vertex Pharmaceuticals Incorporated | $38.33 | 2025 | |
| Lundbeck LLC | $30.68 | 2024-2025 | Rexulti |
| Gilead Sciences, INC. | $25.44 | 2024 | |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
| Hologic Sales and Service, LLC | $24.84 | 2024 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $24.26 | 2023 | |
| Orexo US, INC. | $15.81 | 2024 | Zubsolv |
| Alexion Pharmaceuticals, INC. | $15.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.